Feit C, Tewari R
Infect Immun. 1974; 10(5):1091-7.
PMID: 16558095
PMC: 423067.
DOI: 10.1128/iai.10.5.1091-1097.1974.
YOUMANS A, YOUMANS G
Infect Immun. 1970; 2(5):659-68.
PMID: 16557892
PMC: 416065.
DOI: 10.1128/iai.2.5.659-668.1970.
Smith R, Babiuk L, Stockdale P
Infect Immun. 1981; 31(1):129-35.
PMID: 7216441
PMC: 351761.
DOI: 10.1128/iai.31.1.129-135.1981.
Riottot M, Fournier J, Jouin H
Infect Immun. 1981; 31(1):71-7.
PMID: 7012008
PMC: 351753.
DOI: 10.1128/iai.31.1.71-77.1981.
Cooper M, Tewari R, Bowser D
Infect Immun. 1980; 28(1):92-100.
PMID: 6769823
PMC: 550897.
DOI: 10.1128/iai.28.1.92-100.1980.
Immunogenicity of ribosomes from enzymatically lysed Streptococcus pyogenes.
Green B, Johnson W
Infect Immun. 1980; 27(2):424-30.
PMID: 6155333
PMC: 550782.
DOI: 10.1128/iai.27.2.424-430.1980.
Isolation of protective somatic antigen from Vibrio cholerae (Ogawa) ribosomal preparations.
Jensen R, Gregory B, Naylor J, Actor P
Infect Immun. 1972; 6(2):156-61.
PMID: 4654646
PMC: 422508.
DOI: 10.1128/iai.6.2.156-161.1972.
Response of mice to injection of ribosomal fraction from group B Neisseria meningitidis.
Thomas D, Weiss E
Infect Immun. 1972; 6(3):355-63.
PMID: 4629260
PMC: 422541.
DOI: 10.1128/iai.6.3.355-363.1972.
Vaccines and cell-mediated immunity.
Collins F
Bacteriol Rev. 1974; 38(4):371-402.
PMID: 4613342
PMC: 413869.
DOI: 10.1128/br.38.4.371-402.1974.
Immunity to Salmonella typhimurium infection: characterization of antigens in active protection by polyacrylamide gel electrophoresis.
Houchens D, Wright Jr G
Infect Immun. 1973; 7(3):507-11.
PMID: 4576683
PMC: 422711.
DOI: 10.1128/iai.7.3.507-511.1973.
Ribonucleic acid-protein fractions of virulent Salmonella typhimurium as protective immunogens.
Smith R, Bigley N
Infect Immun. 1972; 6(3):377-83.
PMID: 4564892
PMC: 422544.
DOI: 10.1128/iai.6.3.377-383.1972.
Purification of immunogenically active ribonucleic acid preparations of Salmonella typhimurium: molecular-sieve and anion-exchange chromatography.
Venneman M
Infect Immun. 1972; 5(3):269-82.
PMID: 4564556
PMC: 422361.
DOI: 10.1128/iai.5.3.269-282.1972.
Ribosomal vaccines. I. Immunogenicity of ribosomal fractions isolated from Salmonella typhimurium and Yersinia pestis.
Johnson W
Infect Immun. 1972; 5(6):947-52.
PMID: 4564407
PMC: 422469.
DOI: 10.1128/iai.5.6.947-952.1972.
Protection against Toxoplasma gondii in mice immunized with Toxoplasma cell fractions, RNA and synthetic polyribonucleotides.
Araujo F, Remington J
Immunology. 1974; 27(4):711-21.
PMID: 4215743
PMC: 1445724.
Cell-mediated immunity to Vibrio cholerae with ribonucleic acid-protein fractions of V. cholerae L-form lysates.
Agarwal S, Sundararaj T
Infect Immun. 1976; 14(2):363-7.
PMID: 971951
PMC: 420891.
DOI: 10.1128/iai.14.2.363-367.1976.
Immunogenic activity of a ribosomal fraction obtained from Pasteurella multocida.
Baba T
Infect Immun. 1977; 15(1):1-6.
PMID: 832895
PMC: 421321.
DOI: 10.1128/iai.15.1.1-6.1977.
Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes.
Schalla W, Johnson W
Infect Immun. 1975; 11(6):1195-202.
PMID: 806521
PMC: 415199.
DOI: 10.1128/iai.11.6.1195-1202.1975.
Variability of protection in inbred mice induced by a ribosomal vaccine prepared from Salmonella typhimurium.
Misfeldt M, Johnson W
Infect Immun. 1976; 14(3):652-9.
PMID: 786889
PMC: 420936.
DOI: 10.1128/iai.14.3.652-659.1976.
Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium.
Hoops P, Prather N, Berry J, RAVEL J
Infect Immun. 1976; 13(4):1184-92.
PMID: 776831
PMC: 420736.
DOI: 10.1128/iai.13.4.1184-1192.1976.
Direct evidence for the presence of lipopolysaccharide components in Pseudomonas ribosomal vaccine.
Lieberman M
Infect Immun. 1977; 17(2):471-3.
PMID: 408275
PMC: 421146.
DOI: 10.1128/iai.17.2.471-473.1977.
